Advertisement

Topics

EMA recommends approval of Roche's Ocrevus in relapsing forms of multiple sclerosis

05:03 EST 13 Nov 2017 | Pharmafile

Roche has revealed that its humanised monoclonal antibody Ocrevus (ocrelizumab) received a positive recommendation from the Committee for Medical Products for Human Use (CHMP) in the treatment of active relapsing forms of multiple sclerosis.

read more

Original Article: EMA recommends approval of Roche's Ocrevus in relapsing forms of multiple sclerosis

NEXT ARTICLE

More From BioPortfolio on "EMA recommends approval of Roche's Ocrevus in relapsing forms of multiple sclerosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...